CD30 differential staining is useful in classifying lymphomas intermediate between Hodgkin's disease and anaplastic large cell (Ki1) lymphoma
- PMID: 10080680
- DOI: 10.1177/030089169808400617
CD30 differential staining is useful in classifying lymphomas intermediate between Hodgkin's disease and anaplastic large cell (Ki1) lymphoma
Abstract
Aims and background: The authors analyzed the BerH2 reactivity patterns of the tumor cells in 23 Hodgkin's lymphomas (HD), in 13 CD30+ anaplastic large cell (Ki1) lymphomas (ALCL), in two HD with transition to secondary CD30+ ALCL, and in six additional lymphomas intermediate between HD and ALCL.
Methods: Paraffin blocks of formalin-fixed biopsies were immunostained. Immunostaining was modified by pronase digestion and by microwave assistance.
Results: Hodgkin-Reed-Sternberg (HRS) cells of all 23 Hodgkin's lymphomas were reactive for BerH2, but the reactivity patterns differed: after pronase digestion, HRS cells of 17/23 Hodgkin's lymphomas showed exclusively or at least predominantly cytoplasmic BerH2 reactivity, whereas only four Hodgkin's lymphomas presented with prominent membrane-bound positivity. Microwave processing in 16/23 Hodgkin's lymphomas induced membrane-bound BerH2 positivity in the HRS cells; a minority of five cases retained the distinct cytoplasmic pattern. In contrast, 10/13 ALCLs were characterized by membranous reactions, independent of whether pronase or microwave pretreatment had been applied. The CD30+ ALCLs secondary to HD also showed a tendency towards membranous positivity more than did the antecedent Hodgkin's lymphomas. In the HD/ALCL borderline group, 3/6 cases revealed cytoplasmic BerH2 patterns after pronase digestion and thus were more closely related to HD, whereas 2/6 cases reacted with membranous positivity as did the genuine ALCLs of our series.
Conclusions: We conclude from these findings that the above modifications in CD30 immunostaining can be helpful in the characterization of lymphomas that constitute a continuous histomorphological as well as phenotypical spectrum between HD and ALCL.
Similar articles
-
Expression of Hodgkin's disease associated antigen BLA.36 in anaplastic large cell lymphomas and lymphomatoid papulosis primarily of T-cell origin.Am J Clin Pathol. 1995 Jul;104(1):50-3. doi: 10.1093/ajcp/104.1.50. Am J Clin Pathol. 1995. PMID: 7611181
-
Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.Hum Pathol. 1993 Jul;24(7):725-9. doi: 10.1016/0046-8177(93)90008-5. Hum Pathol. 1993. PMID: 8100553
-
Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.Blood. 1995 Sep 15;86(6):2321-8. Blood. 1995. PMID: 7662979
-
Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.Leuk Lymphoma. 2000 Jul;38(3-4):317-26. doi: 10.3109/10428190009087022. Leuk Lymphoma. 2000. PMID: 10830738 Review.
-
The interface of Hodgkin's disease and anaplastic large cell lymphoma.Cancer Surv. 1997;30:87-105. Cancer Surv. 1997. PMID: 9547988 Review.
Cited by
-
Optimizing assessment of CD30 expression in Hodgkin lymphoma by controlling for low expression.Histol Histopathol. 2024 Mar;39(3):319-331. doi: 10.14670/HH-18-644. Epub 2023 Jun 21. Histol Histopathol. 2024. PMID: 37377225 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical